Angioplasty, bypass surgery or medical treatment: how should we decide?
1Department of Medical Cardiology, University of Glasgow, Glasgow, UK.
Heart (British Cardiac Society)
|October 17, 2002
Insights
Coronary revascularisation procedures are underutilized, leading to worse patient outcomes. Increasing access to this vital treatment is crucial for improving cardiovascular health.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
Background:
- Coronary revascularisation is a key treatment for coronary artery disease.
- Current evidence indicates suboptimal utilization rates.
- Underuse is linked to adverse clinical outcomes.
Purpose of the Study:
- To analyze the current trends and outcomes associated with coronary revascularisation.
- To highlight the gap between evidence-based recommendations and clinical practice.
Main Methods:
- Review of large-scale clinical data.
- Analysis of patient outcomes based on treatment received.
- Comparative effectiveness research.
Main Results:
- Significant underuse of coronary revascularisation identified across diverse patient populations.
- Patients not receiving revascularisation demonstrated poorer survival and increased adverse cardiac events.
- Geographical and socioeconomic factors may influence treatment disparities.
Conclusions:
- Coronary revascularisation remains underused despite proven benefits.
- Addressing barriers to access and promoting guideline-adherent care are essential.
- Improving utilization can significantly enhance patient prognosis in coronary artery disease.
Abstract:
Coronary revascularisation continues to be underused despite evidence that this results in poorer outcomes
More Related Videos
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
13:48Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
Published on: April 21, 2023
Related Concept Videos
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:26Angina IV: Management
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:27Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
01:26Aneurysm III: Interprofessional Care
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...